MPM ASSET MANAGEMENT LLC - Q1 2021 holdings

$518 Million is the total value of MPM ASSET MANAGEMENT LLC's 8 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .

 Value Shares↓ Weighting
ITOS  iTeos Therapeutics, Inc.$126,694,000
+1.1%
3,706,6630.0%24.48%
+38.0%
TCRR  TCR2 Therapeutics, Inc.$89,443,000
-28.6%
4,050,8650.0%17.28%
-2.5%
RPTX SellRepare Therapeutics, Inc.$79,889,000
-22.5%
2,603,089
-13.3%
15.43%
+5.9%
DYN  Dyne Therapeutics, Inc.$76,894,000
-26.0%
4,951,3030.0%14.86%
+1.0%
HARP SellHarpoon Therapeutics, Inc.$67,745,000
-9.9%
3,238,306
-28.4%
13.09%
+23.1%
ONCR  Oncorus, Inc.$39,665,000
-56.9%
2,849,4640.0%7.66%
-41.2%
RYTM SellRhythm Pharmaceuticals, Inc.$19,340,000
-65.9%
909,258
-52.4%
3.74%
-53.5%
CHMA  Chiasma, Inc.$17,955,000
-28.0%
5,736,2960.0%3.47%
-1.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Chiasma, Inc.24Q2 202119.8%
Aratana Therapeutics, Inc.24Q1 201926.8%
Conatus Pharmaceuticals, Inc.23Q1 20199.7%
Rhythm Pharmaceuticals, Inc.19Q2 202269.9%
Harpoon Therapeutics, Inc.19Q3 202331.9%
Syndax Pharmaceuticals, Inc.19Q3 202014.5%
Radius Health, Inc.17Q2 201876.4%
TCR2 Therapeutics, Inc.17Q1 202329.1%
Proteon Therapeutics, Inc.17Q4 20183.0%
EpiZyme, Inc.15Q4 201635.9%

View MPM ASSET MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR/A2023-09-07
13F-HR2023-08-14
42023-06-05
42023-05-24
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11

View MPM ASSET MANAGEMENT LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (517624000.0 != 517625000.0)

Export MPM ASSET MANAGEMENT LLC's holdings